Target
Fatty acid-binding protein 5
Ligand
BDBM312330
Substrate
n/a
Meas. Tech.
Time Resolved-Fluorescence Energy Transfer (TR-FRET) Assay
IC50
20.0±n/a nM
Citation
 Buettelmann, BCeccarelli, SMKuehne, HKuhn, BNeidhart, WObst Sander, URichter, H Bicyclic thiophenylamide compounds US Patent  US9604977 Publication Date 3/28/2017 
Target
Name:
Fatty acid-binding protein 5
Synonyms:
FABP5 | FABP5_HUMAN | Fatty acid binding protein epidermal | Fatty acid-binding protein 5 (FABP5)
Type:
Enzyme
Mol. Mass.:
15164.79
Organism:
Homo sapiens (Human)
Description:
Q01469
Residue:
135
Sequence:
MATVQQLEGRWRLVDSKGFDEYMKELGVGIALRKMGAMAKPDCIITCDGKNLTIKTESTLKTTQFSCTLGEKFEETTADGRKTQTVCNFTDGALVQHQEWDGKESTITRKLKDGKLVVECVMNNVTCTRIYEKVE
  
Inhibitor
Name:
BDBM312330
Synonyms:
2-[4,4-Dimethyl-3-(3-methyl-[1,2,4]oxadiazol-5-yl)-5,6-dihydro-4H-cyclopenta[b]thiophen-2-ylcarbamoyl]-cyclopent-1-enecarboxylic acid | US9604977, Example 77
Type:
Small organic molecule
Emp. Form.:
C19H21N3O4S
Mol. Mass.:
387.453
SMILES:
Cc1noc(n1)-c1c(NC(=O)C2=C(CCC2)C(O)=O)sc2CCC(C)(C)c12 |t:12|
Structure:
Search PDB for entries with ligand similarity: